Featured Research

from universities, journals, and other organizations

Radiating Relief: Researcher Combats Stubborn Arthritis With Neutrons

Date:
January 18, 2000
Source:
Idaho National E & E Laboratory
Summary:
An injection and a few minutes in a gentle beam of neutrons may someday ease the pain of severe rheumatoid arthritis for thousands of Americans. In collaboration with the Department of Energy's Idaho National Engineering and Environmental Laboratory, physicist Jacquelyn Yanch of the Massachusetts Institute of Technology has devised a new way to kill the synovium, the lining that overgrows and ruins a joint afflicted with rheumatoid arthritis.

IDAHO FALLS, Idaho -- An injection and a few minutes in a gentle beam of neutrons may someday ease the pain of severe rheumatoid arthritis for thousands of Americans.

In collaboration with the Department of Energy's Idaho National Engineering and Environmental Laboratory, physicist Jacquelyn Yanch of the Massachusetts Institute of Technology has devised a new way to kill the synovium, the lining that overgrows and ruins a joint afflicted with rheumatoid arthritis. She is testing the technique on rabbits and hopes to test it on humans in a few years.

Yanch injects a boron compound into an arthritic joint and exposes the joint to a beam of subatomic particles called neutrons. The boron absorbs some of the neutrons and forms a radioactive substance that quickly decays. Radiation from the decay kills the synovium and vanishes as soon as the neutron beam is turned off, since boron itself is not radioactive.

In helping develop the new arthritis treatment, INEEL, the DOE's leading nuclear technology laboratory, is applying and expanding its nuclear expertise. Advancing nuclear technologies is one of INEEL's assigned missions. For more than 10 years INEEL has conducted research on boron neutron capture therapy, a treatment for brain tumors that exploits the same interaction between boron and neutrons.

"This is an application for certain key technologies we've developed from the cancer program," said INEEL physicist David Nigg, who is collaborating with Yanch. "We're excited about it."

INEEL is studying the speeds and trajectories of the neutrons in the beam so Yanch and her coworkers can better estimate how much radiation they are administering.

The new technique should be more effective than surgery, which often fails to remove all the diseased tissue. It should be safer than an injection of a radioactive material, which kills the synovium, but leaves radioactivity in the body.

No one knows what initiates or how to cure rheumatoid arthritis, a potentially crippling disease that afflicts more than two million Americans. The disease arises when the immune system mistakenly targets the synovium, the membrane that surrounds a joint and holds in the lubricating synovial fluid. The synovium grows abnormally and invades cartilage and bone, causing them to soften and crumble.

Drugs can often hold the immune system in check. But even after drug therapy, between 10 and 20 percent of patients continue to suffer in at least one joint. Then, the only way to slow the progress of the disease is to get rid of the synovium.

Yanch and her collaborators from MIT, Brigham and Women's Hospital, and Newton Scientific, Inc., are trying their technique on the knees of rabbits with induced rheumatoid arthritis. Early results are promising. "We have very clear evidence that we've killed the synovium," Yanch said, "which is what you want to do."

But more work must be done before Yanch can test the technique on people. For treatment of non-lethal diseases the FDA requires experiments on two different animal species before it will approve experiments with humans, Yanch said.

Yanch thought of the technique in 1992, but the technology began to grow only after she received support from INEEL in 1995. "Most of the development has come with funds we've received through the University Research Consortium," Yanch says. "It's been a big help."

###INEEL's University Research Consortium fosters collaboration between laboratory and university researchers to produce valuable new technologies and address national energy or environmental needs. The consortium funds several projects involving nuclear energy and technology.

The INEEL is managed and operated by Bechtel BWXT, Idaho, LLC (BBWI) for the U.S. Department of Energy.

For more information, see a feature story at http://inelext1.inel.gov/science/feature.nsf/ineel/synovectomy


Story Source:

The above story is based on materials provided by Idaho National E & E Laboratory. Note: Materials may be edited for content and length.


Cite This Page:

Idaho National E & E Laboratory. "Radiating Relief: Researcher Combats Stubborn Arthritis With Neutrons." ScienceDaily. ScienceDaily, 18 January 2000. <www.sciencedaily.com/releases/2000/01/000118062757.htm>.
Idaho National E & E Laboratory. (2000, January 18). Radiating Relief: Researcher Combats Stubborn Arthritis With Neutrons. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/01/000118062757.htm
Idaho National E & E Laboratory. "Radiating Relief: Researcher Combats Stubborn Arthritis With Neutrons." ScienceDaily. www.sciencedaily.com/releases/2000/01/000118062757.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins